What is ANI Pharmaceuticals's total revenue?

ANI Pharmaceuticals (ANIP) reported total revenue of $237.46M in Q1 2026.

How has ANI Pharmaceuticals's total revenue changed year-over-year?

ANI Pharmaceuticals's total revenue increased by 20.5% year-over-year, from $197.12M to $237.46M.

What is the long-term trend for ANI Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), ANI Pharmaceuticals's total revenue has grown at a 42.2% compound annual growth rate (CAGR), from $216.14M to $883.37M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

ANI Pharmaceuticals ANIP Total Revenue

Total Revenue at other companies

Amneal Pharmaceuticals, Inc.AMRX

$722.52M+3.9%

ViatrisVTRS

$3.52B+8.1%

AnaptysBio, Inc.ANAB

$25.56M-8.0%

ALN

Alnylam PharmaceuticalsALNY

$1.17B+96.4%

Aurinia PharmaceuticalsAUPH

$77.71M+24.4%

AmgenAMGN

$8.62B+5.8%

Other financials

Income statement

See full

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's total revenue?: ANI Pharmaceuticals (ANIP) reported total revenue of $237.46M in Q1 2026.
How has ANI Pharmaceuticals's total revenue changed year-over-year?: ANI Pharmaceuticals's total revenue increased by 20.5% year-over-year, from $197.12M to $237.46M.
What is the long-term trend for ANI Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), ANI Pharmaceuticals's total revenue has grown at a 42.2% compound annual growth rate (CAGR), from $216.14M to $883.37M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.